SH-SS and GSH-GSSG Homeostasis in Post-stroke Patients

Sponsor
Abant Izzet Baysal University (Other)
Overall Status
Completed
CT.gov ID
NCT04884555
Collaborator
(none)
77
1
7
11

Study Details

Study Description

Brief Summary

In patients undergoing physical therapy after stroke, extracellular thiol-disulfide balance and intracellular oxidized-reduced glutathione balance levels will be monitored. The main objectives of this study are; (1) to determine the differences between thiol-disulfide and GSH-GSSG balances in stroke patients compared to healthy volunteers, (2) to evaluate the relationship of these balances with the severity of stroke, (3) to determine the predictive value of the levels of these balances on clinical prognosis and functional recovery outcomes, and (4) to investigate and to examine the effects of the physical therapy process on these parameters and functional recovery and their relationship with each other.

Condition or Disease Intervention/Treatment Phase
  • Other: Standard neurorehabilitation
  • Diagnostic Test: Thiol-Disulphide Homeostasis
  • Diagnostic Test: Oxidized-reduced Glutathione Homeostasis

Detailed Description

Stroke is among the most common causes of all deaths and Disability-Adjusted Life Years (DALYs) in the world. There is a close relationship between stroke pathophysiology and post-stroke clinic with oxidative stress. Thiol-disulfide homeostasis systems, which is one of the important extracellular and intracellular oxidative stress markers, showing antioxidant capacity with SH form, and oxidative status with disulfide (SS) form. In this study, we aimed to evaluate the relationship between the clinical outcome of subacute stroke patients and extracellular thiol-disulfide (SH-SS) and intracellular oxidized-reduced glutathione (GSSG-GSH) homeostasis and the comparison of these with healthy volunteers. In addition, the effect of the rehabilitation program on these oxidative stress markers and clinical scores and the predictive value of these oxidative stress parameters on prognosis were also evaluated. The main objectives of this study are; (1) to determine the differences between thiol-disulfide and GSH-GSSG balances in stroke patients compared to healthy volunteers, (2) to evaluate the relationship of these balances with the severity of stroke, (3) to determine the predictive value of the levels of these balances on clinical prognosis and functional recovery outcomes, and (4) to investigate and to examine the effects of the physical therapy process on these parameters and functional recovery and their relationship with each other.

In this study, which is designed as a prospective observational study, patients with subacute stroke who have a stroke for the first time and are admitted to the hospital for the first rehabilitation treatment and healthy volunteers (control group) will be included. The clinical conditions of the patients will be evaluated at the beginning and after the 4-week rehabilitation program at the time of discharge by National Institutes of Health Stroke Scale Scores (NIHSS), modified Rankin Scale (mRS) and Barthel Daily Living Activities Index (BI). Serum and whole blood samples will be obtained from the patient group at the beginning and at discharge, and from the control group. The SH-SS homeostasis parameters (SH, Total SH, SS and SS / SH percent ratio) from serum samples and GSSG-GSH homeostasis parameters (GSH, Total GSH, GSSG and GSSG / GSH percentage ratio) from whole blood samples will be determined. Age, gender, hemiplegic side, type of stroke will be noted. Later, statistical analysis will be conducted.

Study Design

Study Type:
Observational
Actual Enrollment :
77 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Association of Extracellular Thiol-disulfide and Intracellular Oxidized-reduced Glutathione Homeostasis With Severity and Clinical Prognosis of Post-stroke Patients
Actual Study Start Date :
Jul 1, 2020
Actual Primary Completion Date :
Jan 1, 2021
Actual Study Completion Date :
Jan 31, 2021

Arms and Interventions

Arm Intervention/Treatment
post-stroke patient

patients with subacute stroke who have a stroke for the first time and admitted to the hospital for the first rehabilitation treatments

Other: Standard neurorehabilitation
Routine post-stroke rehabilitation

Diagnostic Test: Thiol-Disulphide Homeostasis
Monitoring the levels of thiol and disulphide in serum

Diagnostic Test: Oxidized-reduced Glutathione Homeostasis
Monitoring the levels of intracellular oxidized glutathione and reduced glutathione in whole blood samples

Control

healthy volunteers who have not got any known disease and any sign in physical examination

Diagnostic Test: Thiol-Disulphide Homeostasis
Monitoring the levels of thiol and disulphide in serum

Diagnostic Test: Oxidized-reduced Glutathione Homeostasis
Monitoring the levels of intracellular oxidized glutathione and reduced glutathione in whole blood samples

Outcome Measures

Primary Outcome Measures

  1. NIHSS Scores [at baseline (pre-treatment)]

    National Institutes Of Health Stroke Scale Scores

  2. NIHSS Scores [after 4 weeks of treatment (post-treatment)]

    National Institutes Of Health Stroke Scale Scores

  3. mRS [at baseline (pre-treatment)]

    modified Rankin Scales

  4. mRS [after 4 weeks of treatment (post-treatment)]

    modified Rankin Scales

  5. BI [at baseline (pre-treatment)]

    Barthel Index for Activities of Daily Living

  6. BI [after 4 weeks of treatment (post-treatment)]

    Barthel Index for Activities of Daily Living

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • diagnosis of a first-ever stroke verified by computed tomography (CT) or magnetic resonance imaging (MRI) reports

  • admitted to the hospital for standard neurorehabilitation within 1 to 6 months of stroke onset

  • healthy individuals (for control group)

Exclusion Criteria:
  • significant acute medical illness (e.g., autoimmune disease, infection, tumor, heart failure, renal or liver dysfunction)

  • significant acute neurological illness other than stroke (e.g., head trauma, brain abscess, brain tumor, migraine attack, seizure)

  • cannot adapt to work

  • previous history of neurorehabilitation therapy

  • taking the antioxidant supplements

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bolu Abant Izzet Baysal University Bolu Turkey

Sponsors and Collaborators

  • Abant Izzet Baysal University

Investigators

  • Principal Investigator: Tugba Alisik, MD, Abant Izzet Baysal University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Abant Izzet Baysal University
ClinicalTrials.gov Identifier:
NCT04884555
Other Study ID Numbers:
  • AIBU-FTR-TA-01
First Posted:
May 13, 2021
Last Update Posted:
May 13, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Abant Izzet Baysal University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 13, 2021